Jatenzo
ApprovedActive 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Hypogonadism
Conditions
Hypogonadism
Trial Timeline
May 10, 2024 → Mar 1, 2026
NCT ID
NCT06385509About Jatenzo
Jatenzo is a approved stage product being developed by ICON plc. for Hypogonadism. The current trial status is active. This product is registered under clinical trial identifier NCT06385509. Target conditions include Hypogonadism.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06385509 | Approved | Active |
Competing Products
20 competing products in Hypogonadism